Blog
RSS FeedPosted by Michael Wonder on 18 Jun 2021
Outcomes of the May 2021 PBAC intracycle meeting
18 June 2021 - The outcomes from the May 2021 PBAC meeting are now available. ...
Posted by Michael Wonder on 12 May 2021
Agenda items scheduled for review by the PBAC under the process for reviewing recommendations not accepted by applicants
13 May 2021 - The revised agenda for the July 2021 PBAC meeting notes seven medicines/medicinal preparations for review under ...
Posted by Michael Wonder on 23 Apr 2021
Outcomes from the March 2021 PBAC meeting
23 April 2021 - The outcomes from the March 2021 PBAC meeting are now available. ...
Posted by Michael Wonder on 22 Mar 2021
PBAC publishes sham Public Summary Document for upadacitinib
22 March 2021 - The outcome section makes absolutely no reference to the issue at hand. ...
Posted by Michael Wonder on 08 Mar 2021
Department of Health publishes Public Summary Document for medicine without a published outcome
8 March 2021 - The Department of Health has published a Public Summary Document for mometasone furoate with indacaterol maleate ...
Posted by Michael Wonder on 07 Mar 2021
Where is the corrigenda?
8 March 2021 - Can the Department of Health simply ignore PBAC advice? ...
Posted by Michael Wonder on 05 Mar 2021
PBAC Public Summary Documents - November 2020 meeting
5 March 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2020 PBAC ...
Posted by Michael Wonder on 15 Feb 2021
Post-market review of medicines for smoking cessation – stakeholder forum outcome
15 February 2021 - A stakeholder forum was held for the post-market review of medicines for smoking cessation via webinar on ...
Posted by Michael Wonder on 29 Jan 2021
Recommendations made by the PBAC - December 2020 Intracycle meeting
29 January 2021 - The recommendations from the December 2020 PBAC meeting are now available. ...
Posted by Michael Wonder on 18 Dec 2020
Recommendations made by the PBAC - November 2020
18 December 2020 - The recommendations from the November 2020 PBAC meeting are now available. ...
Posted by Michael Wonder on 29 Nov 2020
PBS support for Australians living with leukaemia
28 November 2020 - Patients living with one of Australia’s most common forms of leukaemia are set to benefit from expanded ...
Posted by Michael Wonder on 18 Oct 2020
PBAC recommends Zeposia for patients with relapsing-remitting multiple sclerosis
16 October 2020 - Did Celgene really request its use for the treatment of non-premenopausal patients with hormone receptor positive, ...
Posted by Michael Wonder on 16 Oct 2020
Recommendations made by the PBAC - September 2020 intracycle meeting and out of session between July 2020 and September 2020 meetings
16 October 2020 - The recommendations from the September 2020 PBAC intracycle meeting are now available. ...
Posted by Michael Wonder on 25 Aug 2020
Insights from the July 2020 PBAC meeting - Insights #4 (outcomes)
25 August 2020 - More insights extracted by the MAESTrO Team from the outcomes from the July 2020 PBAC meeting. ...
Posted by Michael Wonder on 24 Aug 2020
Insights from the July 2020 PBAC meeting - Insight #3 (outcomes)
25 August 2020 - Some outcomes are not clear. ...